- Home
- PROK vs CBAN Comparison
PROK vs CBAN Comparison
Compare PROK & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- CBAN
- Stock Information
- Founded
- PROK 2015
- CBAN 1975
- Country
- PROK United States
- CBAN United States
- Employees
- PROK N/A
- CBAN N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- CBAN Major Banks
- Sector
- PROK Health Care
- CBAN Finance
- Exchange
- PROK Nasdaq
- CBAN Nasdaq
- Market Cap
- PROK 334.8M
- CBAN 279.6M
- IPO Year
- PROK N/A
- CBAN 1998
- Fundamental
- Price
- PROK $2.45
- CBAN $17.20
- Analyst Decision
- PROK Buy
- CBAN
- Analyst Count
- PROK 5
- CBAN 0
- Target Price
- PROK $6.25
- CBAN N/A
- AVG Volume (30 Days)
- PROK 2.4M
- CBAN 49.2K
- Earning Date
- PROK 11-11-2025
- CBAN 10-22-2025
- Dividend Yield
- PROK N/A
- CBAN 2.68%
- EPS Growth
- PROK N/A
- CBAN 24.13
- EPS
- PROK N/A
- CBAN 1.57
- Revenue
- PROK $527,000.00
- CBAN $118,533,000.00
- Revenue This Year
- PROK $265.05
- CBAN $21.97
- Revenue Next Year
- PROK N/A
- CBAN $27.53
- P/E Ratio
- PROK N/A
- CBAN $10.94
- Revenue Growth
- PROK N/A
- CBAN 8.33
- 52 Week Low
- PROK $0.46
- CBAN $13.99
- 52 Week High
- PROK $7.13
- CBAN $18.49
- Technical
- Relative Strength Index (RSI)
- PROK 50.33
- CBAN 54.39
- Support Level
- PROK $2.12
- CBAN $16.92
- Resistance Level
- PROK $3.05
- CBAN $17.52
- Average True Range (ATR)
- PROK 0.23
- CBAN 0.32
- MACD
- PROK 0.03
- CBAN 0.02
- Stochastic Oscillator
- PROK 35.48
- CBAN 44.70
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.